Chronic Unilateral Lumbar Radicular Pain
Effectiveness of Transgrade vs Interlaminar Epidural Steroid Injection for Chronic Unilateral Lumbar Radicular Pain
- Neuropathic Pain
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Ain Shams University
- Enrolment target
- 80
- Started
- 1 November 2023
- Main results due
- 31 October 2026
- Study sites
- 1
- Registry updated
- 24 September 2026
Can you take part?
- Aged 21 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * \> 6-month history of persistent pain in one leg with back pain. * Capable of giving informed consent. * Unsatisfactory response to conventional treatments including physical therapy or medications with a numeric rating scale (NRS) ≥ 5. Exclusion Criteria: * Previous lumbar spinal surgery. * Myelopathy. * Rheumatoid disorders. * Psychiatric disorders * Bleeding or coagulation disorders
What this study is about
In the sponsor’s own words, from the registry.
Chronic neuropathic lumbar pain is among one of the most widespread complaints of patients.Many approaches have been attempted to target chronic pain, with varying efficacy and risks. Transgrade (TG) epidural injection is a new technique using a Racz- Coudé needle for epidural access at a "transgrade" angle without requiring any specialized hardware or accessories. Interlaminar (IL) epidural steroid injection (ESI) is one of the procedures that involves the delivery of injectate to the epidural space through directing a needle between the laminae of two adjacent vertebrae.
Study sites(1)
Ain-Shams University Hospitals
Cairo, Egypt
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT06092749. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me